Sure here you go.... this is the statement they deny ever stating
“PharmaCyte is working on an IND to submit to the FDA so that it can begin a clinical trial involving locally advanced, inoperable, non-metastatic pancreatic cancer and expects to submit its IND later this year.”
Market Data 
Markets 
AI
